Feds Warn of Home Carbon Monoxide Detectors That May Fail to Alarm
CPSC issued the warning after detectors failed tests with a CO concentration of 400 ppm, in violation of safety standards
CPSC issued the warning after detectors failed tests with a CO concentration of 400 ppm, in violation of safety standards
New nasal spray for allergic rhinitis; weight management drug indication is expanded to include teens; monkeypox vaccine access; COVID-19 antibody shelf-life extension; JUUL banned in the US.
Ruling came in response to the company seeking a temporary emergency hold while it appeals an FDA ban of its products
The US Department of HHS added 8 new substances to the 15th Report on Carcinogens, bringing the total list to 256 substances.
Rates of BP control lower for current smokers; 45.5 percent of men had blood pressure >180 and/or >100 mm Hg
Antismoking advocates say the authorization ‘leaves our nation’s youth at an undue risk of addiction’
LYN-014 is an investigational oral, once-weekly, ultra-long-acting, extended-release levomethadone capsule to treat opioid use disorder.
The FDA is concerned that obtaining falsely low test results may lead to inappropriate follow-up assessments, which may result in patient harm.
Brixadi (buprenorphine) is an investigational, extended-release weekly and monthly subcutaneous injection for moderate to severe opioid use disorder.
Signs and symptoms of some neurologic conditions overlap with botulism; thorough, serial neurologic exams should be conducted.